6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	22nd Century Group (Nasdaq: XXII) Launches Pinnacle VLN® Trial in California, Opening Another Major New State for Reduced-Nicotine Cigarettes
Just now	Notification according to Chapter 9, Section 10 of the Securities Market Act
Just now	Astec Industries, Inc. (NASDAQ: ASTE) to Participate in KeyBanc Capital Markets Industrials and Basic Materials Conference on May 27, 2026
Just now	USA Rare Earth Selected for U.S. Department of Energy Funding Under Critical Materials Innovation Program
1m ago	VTech Announces FY2026 Annual Results

About

4.88EUR-0.03 -0.69%

Closed • Updated at 11:40 GMT+00:00

Market Cap$129.46M

Volume71.3K

Beta0.62

RSI62.63

Health TechnologyPharmaceuticals: Major

Ose Immunotherapeutics Sa — investor relations, events, news, and company updates on 6ix.

Latest News

OSE Immunotherapeutics Reports Full Year 2025 Unaudited Consolidated Financial Results and 2026 Q1 Cash Position

OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients

OSE Immunotherapeutics Announces Presentation of TEDOVA Phase 2 Topline Results of Tedopi® in Ovarian Cancer at the ASCO 2026 Meeting

OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting

OSE Immunotherapeutics Evolves its Leadership Team

Community Chat

Ask AI